Development and Validation of a Hypertension Risk Calculator for Living Kidney Donors

Author:

Helgeson Erika S.1,Vempati Shruti1,Palzer Elise F.1,Mjoen Geir2,Haugen Anders J.3,Matas Arthur J.4

Affiliation:

1. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN.

2. Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway.

3. Deptartment of Internal Medicine, Bærum Hospital, Sandvika, Norway.

4. Division of Transplantation, Department of Surgery, University of Minnesota, Minneapolis, MN.

Abstract

Background. Ideally, when deciding whether to donate, kidney donor candidates would understand their long-term risks. Using single-center data (N = 4055; median [quartiles] follow-up: 18 [9–28] y), we developed a calculator for postdonation hypertension and validated it using long-term data from an external single-center cohort (N = 1189, median [quartiles] follow-up: 9 [5–17] y). Methods. Risk factors considered were routinely obtained at evaluation from donor candidates. Two modeling approaches were evaluated: Cox proportional hazards and random survival forest models. Cross-validation prediction error and Harrell’s concordance-index were used to compare accuracy for model development. Top-performing models were assessed in the validation cohort using the concordance-index and net reclassification improvement. Results. In the development cohort, 34% reported hypertension at a median (quartiles) of 16 (8–24) y postdonation; and in the validation cohort, 29% reported hypertension after 17 (10–22) y postdonation. The most accurate model was a Cox proportional hazards model with age, sex, race, estimated glomerular filtration rate, systolic and diastolic blood pressure, body mass index, glucose, smoking history, family history of hypertension, relationship with recipient, and hyperlipidemia (concordance-index, 0.72 in the development cohort and 0.82 in the validation cohort). Conclusions. A postdonation hypertension calculator was developed and validated; it provides kidney donor candidates, their family, and care team a long-term projection of hypertension risk that can be incorporated into the informed consent process.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3